• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.生物疗法与化脓性汗腺炎患者的COVID-19严重程度增加无关：全球化脓性汗腺炎COVID-19登记处的初步发现。
J Am Acad Dermatol. 2022 Jan;86(1):249-252. doi: 10.1016/j.jaad.2021.09.016. Epub 2021 Sep 16.
2
Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.生物疗法与化脓性汗腺炎患者的 COVID-19 严重程度增加无关：来自全球化脓性汗腺炎 COVID-19 登记处的最新发现。
Dermatology. 2023;239(2):283-286. doi: 10.1159/000527401. Epub 2022 Dec 23.
3
Treatment of hidradenitis suppurativa with biologic medications.生物制剂治疗化脓性汗腺炎。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S82-8. doi: 10.1016/j.jaad.2015.07.053.
4
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
5
Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?我们能否延长化脓性汗腺炎生物疗法的药物存活时间？
Clin Exp Dermatol. 2022 Aug;47(8):1585-1586. doi: 10.1111/ced.15232. Epub 2022 Jun 3.
6
Hidradenitis suppurativa perspectives during the COVID-19 pandemic.COVID-19 大流行期间的化脓性汗腺炎展望。
Clin Dermatol. 2023 Sep-Oct;41(5):622-627. doi: 10.1016/j.clindermatol.2023.08.018. Epub 2023 Aug 31.
7
Biologic Treatment for Hidradenitis Suppurativa.生物制剂治疗化脓性汗腺炎。
Am J Clin Dermatol. 2019 Oct;20(5):625-638. doi: 10.1007/s40257-019-00439-5.
8
Biologic use in hidradenitis suppurativa: patient perspectives and barriers.生物制剂在化脓性汗腺炎中的应用：患者视角和障碍。
J Dermatolog Treat. 2022 Nov;33(7):3060-3062. doi: 10.1080/09546634.2022.2089336. Epub 2022 Jul 10.
9
Moderate to severe hidradenitis suppurativa treated with biological therapies.采用生物疗法治疗中度至重度化脓性汗腺炎。
Australas J Dermatol. 2014 May;55(2):128-31. doi: 10.1111/ajd.12136. Epub 2014 Jan 23.
10
Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world setting.阿达木单抗联合手术与阿达木单抗单药治疗化脓性汗腺炎的比较：真实世界环境中的一项随机对照试验。
J Am Acad Dermatol. 2023 Oct;89(4):677-684. doi: 10.1016/j.jaad.2023.04.034. Epub 2023 Apr 27.

引用本文的文献

1
Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications.新冠疫情时代的自身免疫性皮肤病：病理生理学见解与临床意义
Microorganisms. 2025 Sep 11;13(9):2129. doi: 10.3390/microorganisms13092129.
2
Hidradenitis Suppurativa in the SARS-CoV-2 Pandemic: Investigation of Trigger Factors in a Single Center.2019冠状病毒病大流行期间的化脓性汗腺炎：单中心触发因素调查
J Clin Med. 2024 Jul 12;13(14):4074. doi: 10.3390/jcm13144074.
3
A critical review of COVID-19 course and vaccination in dermatology patients on immunomodulatory/biologic therapy: recommendations should not differ between non-pregnant and pregnant individuals.对接受免疫调节/生物治疗的皮肤科患者的COVID-19病程和疫苗接种的批判性综述：非孕妇和孕妇的建议不应有所不同。
Front Med (Lausanne). 2023 Jun 2;10:1121025. doi: 10.3389/fmed.2023.1121025. eCollection 2023.
4
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.远程皮肤病学在2019年冠状病毒病大流行期间的作用：一项叙述性综述
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
5
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.化脓性汗腺炎患者新冠疫苗接种指南：专家修改后的德尔菲共识
Skin Appendage Disord. 2022 Jul;8(4):287-290. doi: 10.1159/000521268. Epub 2022 Jan 10.

Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.

作者信息

Naik Haley B, Alhusayen Raed, Frew John, Guilbault Sandra, Hills Nancy K, Ingram John R, Kudlinski Margaret V, Lowes Michelle A, Marzano Angelo Valerio, Paul Maia, Villumsen Bente, Yannuzzi Christine A

机构信息

Department of Dermatology, University of California, San Francisco, California.

Dermatology Division, Department of Medicine, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Am Acad Dermatol. 2022 Jan;86(1):249-252. doi: 10.1016/j.jaad.2021.09.016. Epub 2021 Sep 16.

DOI:10.1016/j.jaad.2021.09.016
PMID:34537252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8443529/
Abstract
摘要